Studies have reported that increased CSF MCP-1 levels are linked to lower MMSE scores, and greater baseline levels predict a faster rate of cognitive deterioration in the early stages of Alzheimer’s disease [24]. The gene discussed is CCL2; the disease is early-onset autosomal dominant Alzheimer disease.